Folate transporter 1

(Redirected from SLC19A1)

Folate transporter 1 is a protein which in humans is encoded by the SLC19A1 gene.[5]

SLC19A1
Identifiers
AliasesSLC19A1, CHMD, FOLT, IFC1, REFC, RFC1, solute carrier family 19 member 1, IFC-1, RFC, hRFC, RFT-1, hMEGAF
External IDsOMIM: 600424; MGI: 103182; HomoloGene: 57139; GeneCards: SLC19A1; OMA:SLC19A1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001199271
NM_031196

RefSeq (protein)

NP_001186200
NP_112473

Location (UCSC)Chr 21: 45.49 – 45.57 MbChr 10: 77.03 – 77.06 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

Transport of folate compounds into mammalian cells can occur via receptor-mediated (see folate receptor 1) or carrier-mediated mechanisms. A functional coordination between these 2 mechanisms has been proposed to be the method of folate uptake in certain cell types. Methotrexate (MTX) is an antifolate chemotherapeutic agent that is actively transported by the carrier-mediated uptake system. RFC1 plays a role in maintaining intracellular concentrations of folate.[6] SLC19A1 has also been shown to transport the immune second messenger 2'3'-cGAMP.[7]

Clinical significance

Individuals carrying a specific polymorphism of SLC19A1 (c.80GG) have lower levels of folate.[8] Other studies have also shown that individuals carrying the c.80AA polymorphism who are treated with methotrexate have higher levels of this anti-folate chemotherapeutic agent. Personalized dosing of the drug depending on the patient's genotype may therefore be required.

Alternative names

  • Reduced folate carrier 1
  • Intestinal folate carrier 1

See also

References

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.